NO174051C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser

Info

Publication number: NO174051C
Authority: NO; Norway
Prior art keywords: tetrazolyl; triazolyl; therapeutically active; analogous process; pyrazolyl compounds
Prior art date: 1987-06-24

Application number

NO882799A

Other languages

English (en)

Norwegian (no)

Other versions

NO174051B (no

NO882799L (no

NO882799D0 (no

Inventor

Klaus Peter Boegesoe

Klaus Gundertofte Jensen

Ejner Knud Moltzen

Henrik Pedersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-24

Filing date

1988-06-23

Publication date

1994-03-09

1988-06-23 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1988-06-23 Publication of NO882799D0 publication Critical patent/NO882799D0/no

1988-12-27 Publication of NO882799L publication Critical patent/NO882799L/no

1993-11-29 Publication of NO174051B publication Critical patent/NO174051B/no

1994-03-09 Publication of NO174051C publication Critical patent/NO174051C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO882799A 1987-06-24 1988-06-23 Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser NO174051C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878714789A GB8714789D0 (en)	1987-06-24	1987-06-24	Heterocyclic compounds

Publications (4)

Publication Number	Publication Date
NO882799D0 NO882799D0 (no)	1988-06-23
NO882799L NO882799L (no)	1988-12-27
NO174051B NO174051B (no)	1993-11-29
NO174051C true NO174051C (no)	1994-03-09

Family

ID=10619472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882799A NO174051C (no)	1987-06-24	1988-06-23	Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser

Country Status (19)

Country	Link
US (3)	US4866077A (pt)
EP (1)	EP0296721B1 (pt)
JP (1)	JP2703268B2 (pt)
AU (1)	AU615917B2 (pt)
BR (1)	BR1100658A (pt)
CA (1)	CA1340458C (pt)
DE (1)	DE3881970T2 (pt)
DK (1)	DK168600B1 (pt)
ES (1)	ES2056928T3 (pt)
FI (1)	FI93356C (pt)
GB (1)	GB8714789D0 (pt)
HK (1)	HK84194A (pt)
HU (1)	HU210809A9 (pt)
IE (1)	IE61694B1 (pt)
IL (1)	IL86618A (pt)
NO (1)	NO174051C (pt)
NZ (1)	NZ224868A (pt)
PT (1)	PT87820B (pt)
ZA (1)	ZA884339B (pt)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2053748T3 (es) *	1987-09-10	1994-08-01	Merck Sharp & Dohme	Oxazoles y tiazoles para el tratamiento de la demencia senil.
IE63906B1 (en) *	1987-11-13	1995-06-14	Novo Nordisk As	Azabicyclic compounds and their preparation and use
ATE87918T1 (de) *	1988-02-19	1993-04-15	Lilly Co Eli	Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
DK162892C (da) *	1988-07-04	1992-05-11	Novo Nordisk As	1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
IT1229491B (it) *	1988-12-28	1991-09-03	Roussel Maestretti S P A Ora R	Derivati della 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro impiego come sostanze medicinali
JP3003148B2 (ja) *	1989-01-05	2000-01-24	藤沢薬品工業株式会社	チアゾール化合物、その製造法およびそれを含有する医薬組成物
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
US5260311A (en) *	1989-02-22	1993-11-09	Novo Nordisk A/S	Piperidine compounds and their use
US5264444A (en) *	1989-02-22	1993-11-23	Novo Nordisk A/S	Piperidine compounds and use
US5328925A (en) *	1989-02-22	1994-07-12	Novo Nordisk A/S	Piperidine compounds and their use
EP0402056A3 (en) *	1989-06-06	1991-09-04	Beecham Group p.l.c.	Azabicyclic compounds, process for their preparation and pharmaceutical compositions containing them
EP0427390B1 (en) *	1989-10-07	1996-03-27	Beecham Group Plc	Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
US5200419A (en) *	1990-05-21	1993-04-06	Warner-Lambert Company	Substituted tetrazoles and derivatives thereof acting at muscarinic receptors
IE911994A1 (en) *	1990-07-03	1992-01-15	Akzo Nv	5-isothiazolamine derivatives
US5376668A (en) *	1990-08-21	1994-12-27	Novo Nordisk A/S	Heterocyclic compounds
US5418240A (en) *	1990-08-21	1995-05-23	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5527813A (en) *	1990-08-21	1996-06-18	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
USRE35822E (en) *	1990-08-21	1998-06-09	Novo Nordisk A/S	Heterocyclic compounds
DK198590D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198490D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) *	1990-08-21	1990-08-21	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling og anvendelse
ES2113939T3 (es) *	1990-11-29	1998-05-16	Allergan Inc	Uso de derivados de piridina en el tratamiento de la hipertension ocular.
JPH06510021A (ja) *	1991-03-13	1994-11-10	ザリージェンツオブザユニバーシティオブミネソタ	アルツハイマー病検出用の放射性薬剤
IE922270A1 (en) *	1991-07-26	1993-01-27	Akzo Nv	Pyrazole derivatives
US5641791A (en) *	1991-08-13	1997-06-24	Novo Nordisk A.S	Heterocyclic compounds and their preparation and use
US5175166A (en) *	1991-08-27	1992-12-29	The University Of Toledo	Muscarinic agonists
WO1993014089A1 (en) *	1992-01-13	1993-07-22	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5330994A (en) *	1992-03-24	1994-07-19	Warner-Lambert Company	Tetrahydropyridine isoxazoline derivatives
ES2133416T3 (es) *	1992-10-23	1999-09-16	Merck Sharp & Dohme	Ligandos de subtipos de receptores de dopamina.
US5753683A (en) *	1993-08-19	1998-05-19	Novo Nordisk A/S	Antipsychotic method
US5612351A (en) *	1994-11-08	1997-03-18	Novo Nordisk A/S	Method of treating urinary bladder dysfunctions
US5668148A (en) *	1995-04-20	1997-09-16	Merck & Co., Inc.	Alpha1a adrenergic receptor antagonists
AU6299296A (en) *	1995-06-29	1997-01-30	Novo Nordisk A/S	Novel substituted azacyclic compounds
CZ287441B6 (en) *	1995-11-06	2000-11-15	Lundbeck & Co As H	Pharmaceutical preparation for treating traumatic lesion of brain
AU2568597A (en) *	1996-04-24	1997-11-12	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
US5733912A (en) *	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
JP2002500651A (ja) *	1997-05-29	2002-01-08	ハー・ルンドベック・アクティーゼルスカブ	精神分裂病及び精神病の治療方法
AR013096A1 (es) *	1997-07-01	2000-12-13	Lundbeck & Co As H	Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP1017386A1 (en) *	1997-10-02	2000-07-12	H. Lundbeck A/S	GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE
IL140540A0 (en) *	1998-07-27	2002-02-10	Lilly Co Eli	Treatment of anxiety disorders
AU6686700A (en) *	1999-08-23	2001-03-19	H. Lundbeck A/S	Treatment of urinary incontinence
EP1274424A4 (en) *	2000-04-12	2003-09-17	Smithkline Beecham Corp	CONNECTIONS AND PROCEDURE
WO2002085897A1 (en) *	2001-04-05	2002-10-31	Alangudi Sankaranarayanan	Heterocyclic compounds for aging-related and diabetic vascular complications
US20030069597A1 (en) *	2001-10-10	2003-04-10	Scimed Life Systems, Inc.	Loading tool
AU2002360403A1 (en) *	2001-11-19	2003-06-10	Elan Pharmaceuticals, Inc.	(4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of Alzheimer's disease
WO2004060371A1 (en)	2002-12-18	2004-07-22	Fmc Corporation	N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
JP2006516140A (ja) *	2002-12-20	2006-06-22	メルク　エンド　カムパニー　インコーポレーテッド	有糸分裂キネシン阻害剤
JP2007523202A (ja) *	2004-02-24	2007-08-16	ビオアクソン・テラプティーク・インコーポレーテッド	４置換ピペリジン誘導体
US20060224175A1 (en) *	2005-03-29	2006-10-05	Vrba Anthony C	Methods and apparatuses for disposition of a medical device onto an elongate medical device
EP2258359A3 (en)	2005-08-26	2011-04-06	Braincells, Inc.	Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2275096A3 (en)	2005-08-26	2011-07-13	Braincells, Inc.	Neurogenesis via modulation of the muscarinic receptors
EP1940389A2 (en)	2005-10-21	2008-07-09	Braincells, Inc.	Modulation of neurogenesis by pde inhibition
JP2009513672A (ja)	2005-10-31	2009-04-02	ブレインセルス，インコーポレイティド	神経発生のｇａｂａ受容体媒介調節
US20100216734A1 (en)	2006-03-08	2010-08-26	Braincells, Inc.	Modulation of neurogenesis by nootropic agents
EP2382975A3 (en)	2006-05-09	2012-02-29	Braincells, Inc.	Neurogenesis by modulating angiotensin
CA2651862A1 (en)	2006-05-09	2007-11-22	Braincells, Inc.	5 ht receptor mediated neurogenesis
KR20090064418A (ko)	2006-09-08	2009-06-18	브레인셀즈 인코퍼레이션	4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en)	2006-09-19	2010-07-22	Braincells, Inc.	Modulation of neurogenesis by ppar agents
US8084473B2 (en)	2007-04-24	2011-12-27	Solvay Pharmaceuticals B.V.	Heterocyclic compounds with affinity to muscarinic receptors
CN101939311A (zh) *	2007-04-24	2011-01-05	索尔瓦药物有限公司	对毒蕈碱受体具有亲和力的杂环类化合物
EP2296471A4 (en)	2008-05-15	2012-03-14	Univ Toledo	MUSCARIC ACID AGONISTS AS COGNITIVE ENHANCERS
WO2010099217A1 (en)	2009-02-25	2010-09-02	Braincells, Inc.	Modulation of neurogenesis using d-cycloserine combinations
SG175422A1 (en) *	2009-05-07	2011-11-28	Torrent Pharmaceuticals Ltd	Piperidine derivatives useful for treatment of diebetes
ES2603032T3 (es)	2010-07-15	2017-02-23	Bayer Intellectual Property Gmbh	Compuestos de 3-piridil-heteroarilcarboxamida como pesticidas
WO2012052412A1 (de)	2010-10-22	2012-04-26	Bayer Cropscience Ag	Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
WO2012149524A1 (en)	2011-04-29	2012-11-01	The University Of Toledo	Muscarinic agonists as enhancers of working memory and cognitive flexibility
CN103848850B (zh) *	2013-08-28	2016-03-23	沈阳东瑞精细化工有限公司	一种舒巴坦的制备方法
US10149856B2 (en)	2015-01-26	2018-12-11	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US10106525B2 (en)	2015-01-26	2018-10-23	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10857157B2 (en)	2015-01-26	2020-12-08	BioAxone BioSciences, Inc.	Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
US11198680B2 (en)	2016-12-21	2021-12-14	BioAxone BioSciences, Inc.	Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
WO2019014322A1 (en)	2017-07-11	2019-01-17	BioAxone BioSciences, Inc.	KINASE INHIBITORS FOR THE TREATMENT OF DISEASES
US20230365542A1 (en) *	2020-09-28	2023-11-16	The Regents Of The University Of California	Selective Agonists of 5-HT2A Receptor and Methods of Use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2659739A (en)	1950-04-14	1953-11-17	Eastman Kodak Co	1-hydroxy-4-beta-cyanopropylamino-anthraquinone and process for preparing same
BE845612A (fr) *	1976-03-23	1977-02-28		Derives de tetrazole-5-carboxamide et leur preparation
US4431653A (en) *	1982-03-18	1984-02-14	Hoffmann-La Roche Inc.	Penicillanic acid derivatives
DE3421072A1 (de) *	1984-06-06	1985-12-12	Heinrich Mack Nachf., 7918 Illertissen	1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4650805A (en) *	1985-12-02	1987-03-17	Warner-Lambert Company	4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
NZ219646A (en) *	1986-03-27	1990-10-26	Merck Sharp & Dohme	Oxadiazole derivatives of azacyclics for treating cns disorders
GB8610432D0 (en) *	1986-04-29	1986-06-04	Akzo Nv	Amino-thiazole & oxazole derivatives
IL83275A (en) *	1986-09-08	1994-02-27	Novo Nordisk As	Substituted 1, 2, 4- oxadiazolyl piperidine compounds, their preparation and pharmaceutical compositions containing them
IE63906B1 (en) *	1987-11-13	1995-06-14	Novo Nordisk As	Azabicyclic compounds and their preparation and use
EP0372125A1 (en) *	1988-11-08	1990-06-13	Akzo N.V.	Oxazole and thiazole derivatives

1987
- 1987-06-24 GB GB878714789A patent/GB8714789D0/en active Pending
1988
- 1988-05-27 ES ES88304899T patent/ES2056928T3/es not_active Expired - Lifetime
- 1988-05-27 DE DE88304899T patent/DE3881970T2/de not_active Expired - Lifetime
- 1988-05-27 EP EP88304899A patent/EP0296721B1/en not_active Expired - Lifetime
- 1988-05-30 IE IE163188A patent/IE61694B1/en not_active IP Right Cessation
- 1988-06-01 NZ NZ224868A patent/NZ224868A/en unknown
- 1988-06-03 IL IL86618A patent/IL86618A/xx not_active IP Right Cessation
- 1988-06-13 DK DK321688A patent/DK168600B1/da not_active IP Right Cessation
- 1988-06-17 ZA ZA884339A patent/ZA884339B/xx unknown
- 1988-06-22 US US07/209,994 patent/US4866077A/en not_active Ceased
- 1988-06-22 CA CA000570135A patent/CA1340458C/en not_active Expired - Lifetime
- 1988-06-23 AU AU18282/88A patent/AU615917B2/en not_active Expired
- 1988-06-23 NO NO882799A patent/NO174051C/no not_active IP Right Cessation
- 1988-06-23 FI FI883064A patent/FI93356C/fi active IP Right Grant
- 1988-06-24 JP JP63155095A patent/JP2703268B2/ja not_active Expired - Lifetime
- 1988-06-24 PT PT87820A patent/PT87820B/pt not_active IP Right Cessation
1989
- 1989-04-26 US US07/343,848 patent/US4925858A/en not_active Expired - Lifetime
1994
- 1994-08-18 HK HK84194A patent/HK84194A/en not_active IP Right Cessation
1995
- 1995-03-08 HU HU95P/P00089P patent/HU210809A9/hu unknown
1996
- 1996-05-13 US US08/648,240 patent/USRE36374E/en not_active Expired - Lifetime
1997
- 1997-05-07 BR BR1100658-7A patent/BR1100658A/pt active IP Right Grant

Also Published As

Publication number	Publication date
HK84194A (en)	1994-08-26
AU1828288A (en)	1989-01-05
DK321688D0 (da)	1988-06-13
JPS6422869A (en)	1989-01-25
IE61694B1 (en)	1994-11-16
ES2056928T3 (es)	1994-10-16
PT87820B (pt)	1992-10-30
DE3881970D1 (de)	1993-07-29
USRE36374E (en)	1999-11-02
PT87820A (pt)	1989-05-31
IL86618A0 (en)	1988-11-30
DK168600B1 (da)	1994-05-02
FI93356B (fi)	1994-12-15
US4925858A (en)	1990-05-15
BR1100658A (pt)	1999-08-31
HU210809A9 (en)	1995-08-28
FI883064A0 (fi)	1988-06-23
AU615917B2 (en)	1991-10-17
CA1340458C (en)	1999-03-23
EP0296721A3 (en)	1990-04-25
FI883064A7 (fi)	1988-12-25
DK321688A (da)	1988-12-25
GB8714789D0 (en)	1987-07-29
NO174051B (no)	1993-11-29
DE3881970T2 (de)	1993-11-11
EP0296721A2 (en)	1988-12-28
EP0296721B1 (en)	1993-06-23
NO882799L (no)	1988-12-27
ZA884339B (en)	1989-05-30
NZ224868A (en)	1990-07-26
IL86618A (en)	1992-07-15
NO882799D0 (no)	1988-06-23
FI93356C (fi)	1995-03-27
US4866077A (en)	1989-09-12
IE881631L (en)	1988-12-24
JP2703268B2 (ja)	1998-01-26

Publication	Publication Date	Title
NO174051C (no)	1994-03-09	Analogifremgangsmåte ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser
FI882882A7 (fi)	1988-12-17	Menetelmä terapeuttisesti aktiivisten (substituoitu aralkyyli)triatsoli-, -imidatsoli-, -pyridiini- ja -pyrimidiiniyhdisteiden valmistamiseksi
NO174547C (no)	1994-05-25	Analogifremgangsmåte ved fremstilling av terapeutisk aktive didehydro-vitamin-D3-derivater
NO180586C (no)	1997-05-14	Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO174385C (no)	1994-04-27	Analogifremgangsmåte ved fremstilling av terapeutisk aktive spiro-substituerte glutamid-derivater
NO176796C (no)	1995-05-31	Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO179283C (no)	1996-09-11	Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
EG19303A (en)	1994-11-30	Process for preparing of new therapeutically active compound
FI893809L (fi)	1990-02-14	Menetelmä terapeuttisesti käyttökelpoisten fungisidisten triatsoliyhdisteiden valmistamiseksi
NO178619C (no)	1996-05-02	Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI872785A7 (fi)	1987-12-24	Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
HU912665D0 (en)	1992-01-28	Process for producing heterocyclic imidazoles and pharmaceutical preparatives containing said compounds
NO178498C (no)	1996-04-10	Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
NO175429C (no)	1994-10-12	Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO165841C (no)	1991-04-17	Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO175714C (no)	1994-11-23	Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
FI893883A7 (fi)	1989-08-17	Menetelmä terapeuttisesti aktiivisten 7-tetrahydronaftyridiini-6-fluori-1,4-dihydro-4-oksokinoliini-3-karboksyylihappojen valmistamiseksi
NO174959C (no)	1994-08-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI882030A7 (fi)	1988-10-31	Menetelmä terapeuttisesti aktiivisten polysyklisten heterosyklisten yhdisteiden valmistamiseksi
NO178069C (no)	1996-01-17	Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
NO178967C (no)	1996-07-10	Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
EP0175312A3 (en)	1987-04-29	Process for preparing optically active hydantoins
NO175781C (no)	1994-12-07	Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
NO176100C (no)	1995-02-01	Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174200C (no)	1994-04-06	Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser

Legal Events

Date	Code	Title	Description
2008-08-11	MK1K	Patent expired